Hardik G. Jani

Hardik G. Jani

Hospital Medicine

112 North 7th Street
Chambersburg, PA 17201

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice.

mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice.

Journal: Vaccine

Published: January 03, 2025

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant.

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant.

Journal: bioRxiv : the preprint server for biology

Published: October 20, 2022

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.

Journal: Nature medicine

Published: September 14, 2022

Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice.

Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice.

Journal: Frontiers in immunology

Published: May 19, 2022

Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.

Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.

Journal: Vaccine

Published: July 02, 2021

Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.

Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.

Journal: bioRxiv : the preprint server for biology

Published: April 21, 2021

Showing 1-6 of 6

Last Updated: 09/26/2026